As we explore the world of healthcare AI, it’s crucial to find a balance between regulation, innovation, and market access. During this session, we’ll discuss the guiding principles of AI and how collaboration with patients, clinicians, and scientists is essential to establish sound standards. Achieving these benchmarks not only facilitates market penetration but also highlights the significance of regulation in driving innovation.
Robin Carpenter
AI Ethics & Governance Lead, AI Centre for Value Based Healthcare
Jeanette Kusel
Director for Scientific Advice, NICE
Jeanette is responsible for the stewardship and growth of the NICE engagement services for the life sciences industry, including digital and AI developers. She chairs many of the national and parallel scientific advice meetings and is the NICE senior responsible officer for the AI and Digital Regulatory Service.
Previously Jeanette held the positions of head of health technology assessment and health economics and scientific director at Costello Medical, a consultancy within the life science sector. She has broad research interests across different methods for health technology evaluation and has previously worked on evaluation of AI health technologies, health economic modelling and quality of life measurement.
Jeanette studied undergraduate natural sciences at the University of Cambridge and postgraduate health economics at the University of York.
Vishal Thakker
Head of UK Approved Body, BSI
Currently the Head of the UK Approved Body for Medical Devices at BSI. He is responsible for the regulatory oversight of the Medical Devices Approved Body and wider strategy, policies, and procedures, to meet the various legislative and designation requirements. He has held various roles within BSI over the past 8 years with expertise in Active Devices including AI.
Chair: Ele Harwich
Director, Newmarket Strategy
Ele has deep expertise in digital health with a focus on AI and regulation. She previously worked at the NHS AI Lab where she led on two key reports looking at the evaluation of AI-enabled medical devices, and ways to develop and deploy AI-enabled medical devices across jurisdictions. She is also a member of the BSI.
